Nalaganje...
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
BACKGROUND: Clinical trials have established the efficacy of ranibizumab for the treatment of neovascular age-related macular degeneration (AMD). In addition, bevacizumab is used off-label to treat AMD, despite the absence of similar supporting data. METHODS: In a multicenter, single-blind, noninfer...
Shranjeno v:
| Format: | Artigo |
|---|---|
| Jezik: | Inglês |
| Izdano: |
2011
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3157322/ https://ncbi.nlm.nih.gov/pubmed/21526923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1102673 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|